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Abstract: The presence of two known anthraquinones, Lupinacidin A and Galvaquinone B, which
have antitumor activity, has been identified in the sea anemone (Gyractis sesere) from Easter Island.
So far, these anthraquinones have been characterized from terrestrial and marine Actinobacteria only.
In order to identify the anthraquinones producer, we isolated Actinobacteria associated with the sea
anemone and obtained representatives of seven actinobacterial genera. Studies of cultures of these
bacteria by HPLC, NMR, and HRLCMS analyses showed that the producer of Lupinacidin A and
Galvaquinone B indeed was one of the isolated Actinobacteria. The producer strain, SN26_14.1, was
identified as a representative of the genus Verrucosispora. Genome analysis supported the biosynthetic
potential to the production of these compounds by this strain. This study adds Verrucosispora as
a new genus to the anthraquinone producers, in addition to well-known species of Streptomyces
and Micromonospora. By a cultivation-based approach, the responsibility of symbionts of a marine
invertebrate for the production of complex natural products found within the animal’s extracts could
be demonstrated. This finding re-opens the debate about the producers of secondary metabolites in
sea animals. Finally, it provides valuable information about the chemistry of bacteria harbored in the
geographically-isolated and almost unstudied, Easter Island.
Keywords: Easter Island; Actinobacteria; anthraquinones; symbionts; sea anemone; marine
invertebrates; spectroscopy; chromatography
1. Introduction
Since the discovery of Easter Island, compelling explorations have characterized the flora [1]
and fauna [2–4] of this geographically isolated location. However, little has been done to understand
the chemistry harbored in this territory. The best-known finding is the discovery of rapamycin in
a soil dwelling actinobacterial representative, which serves as an immunosuppressive drug [5,6].
Beyond that, little progress has been made in exploiting the chemical diversity harbored by marine
invertebrates and microorganisms dwelling in this territory, despite the high degree of endemism
found [7].
Marine invertebrates are immensely diverse, well distributed in the world oceans [8], and widely
known to contain medicinally relevant molecules [9–11]. While these metabolites play different roles in
nature, e.g., they act as chemical defense, chemical communication or reproductive signaling molecules,
they also find application as human medicines [12]. During the last decades, much effort has been
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made to identify and characterize the chemicals contained in marine invertebrates. This has resulted in
the discovery of astonishing chemicals with novel biological activities and chemical scaffolds [12–14].
Further, the immense progress in DNA sequencing technologies, the development of
bioinformatics, and an improvement in analytical techniques enables the identification of the source of
the chemicals. Thus, several molecules contained in marine invertebrates have now been shown to
actually be of microbial origin [15,16]. It is expected that with the increasing availability of metagenomic
information more identifications of the real producers of these metabolites will be made and will
establish the metabolite relevance for the interaction of host, symbiont, and the environment.
Marine sponges represent a classic example of marine invertebrates that harbor microbes
producing secondary metabolites. They have been studied in detail to determine the origin of the
metabolites [17,18]. Another example is the producer of the approved anticancer drug Yondelis
(Ecteinascidin-743). This compound was first assigned to the tunicate Ecteinascidia turbinata, but later
identified as the product of a microbe, Candidatus Endoecteinascidia frumentensis [16].
Anthraquinones have been characterized in different marine invertebrates, for example
crinoids [19] and sponges [20]. Anthraquinones have broad biological activity and are substances of
pharmaceutical relevance for revealing antitumor [21], antibacterial [22], antifungal [23] and epigenetic
modulator activities [24]. Two recently isolated anthraquinones, Lupinacidin A (1) and Galvaquinone
B (2), have been reported to be produced by Actinobacteria belonging to the genera Streptomyces and
Micromonospora. Lupinacidin A (1) was firstly reported as a specific inhibitor on murine colon 26-L5
carcinoma cells [25], and Galvaquinone B (2) showed moderate cytotoxicity against non-small-cell
lung cancer cells Calu-3 and H2887, in addition of epigenetic modulatory activity [24].
Herein, we report the identification of two known anthraquinone molecules, Lupinacidin A (1)
and Galvaquinone B (2), contained in an Easter Island sea anemone, Gyractis sesere. Interestingly,
so far these molecules have been only characterized from microbial origin. Therefore, we undertook
the isolation and culture of the Actinobacteria associated with this marine invertebrate. The culture,
chemical and genomic evaluation of these bacteria showed that the real producer of the metabolites
was an Actinobacterium belonging to the genus Verrucosispora and not the sea anemone.
2. Results and Discussion
2.1. Sea Anemone Dereplication
Samples of the sea anemone Gyractis sesere [26], also known as Actiniogeton rapanuiensis [27],
were collected in the intertidal zone of Easter Island, South Pacific Ocean, and extracted with
chloroform to give 8 mg of a yellowish residue. The HRLCMS analysis of this crude extract showed
the presence of two previously identified antitumor anthraquinones (Figure 1) [24,25], Lupinacidin A
(1) ([M + H]+ m/z 341.1378) and Galvaquinone B (2) ([M + H]+ m/z 369.3510), which were confirmed
by complete NMR-spectroscopic characterization.Mar. Drugs 2019, 17, x FOR PEER REVIEW 3 of 15 
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Interestingly, the crude extract of the sea anemone (Figure 2) shows five resonances above 10 ppm;
a region which is characteristic for hydroxyl protons. The resonances at δ 14.18 and 12.96 ppm are
assigned to the groups at C-1 and C-6 of Lupinacidin A (1), as their vicinity and consequential hydrogen
bonding to the ketogroups slows down their exchange. Similarly, the resonances at δ 13.49, 12.50,
and 12.14 ppm originate from the three hydroxylprotons in Galvaquinone B (2).
Mar. Drugs 2019, 17, x FOR PEER REVIEW 3 of 15 
 
 
 
Figure 1. Identified molecules from the Easter Island sea anemone Gyractis sesere. 
 
Figure 2. Chemical analysis of the crude extract of the sea anemone Gyractis sesere. A) 1H NMR spectra 
of the crude extract of marine anemone Gyractis sesere acquired in CDCl3, 600 MHz. Highlighted in 
the zoomed area are the frequencies of characteristic resonances originating from hydroxyl  
 
Figure 2. Chemical n lysis of the crude xtract of the sea is sesere. (A) 1H NMR spectra
of the crude extract of marine anemone Gyractis sesere acquired in CDCl3, 600 MHz. Highlighted in the
zoomed area are the frequencies of characteristic resonances originating from hydroxyl exchangeable
protons in vicinity to ketogroups. (B) UV chromatogram (254 nm) of the crude extract of the sea
anemone Gyractis sesere highlighting the specific peaks for RT: 24.3 min, and N: RT: 25.2 min. (C)
High resolution mass for  (m/z [M + H]+ 341.1378) and (D) high resolution mass for N (2) (m/z
[M + H]+ 369.3510). *RT: Retention Time.
Other main peaks found in the sea anemone crude extract were peaks at RT 14.2 min with a
HRMS [M + H]+ m/z 295.19009 and at RT 23 min with a HRMS [M + H]+ m/z 256.26312. Both exact
masses were evaluated using the MarinLit database, however their HRMS did not match any known
compound to-date.
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2.2. Bacterial Metabolites and Harbored Bacteria
Lupinacidin A (1) and Galvaquinone B (2) have so far only been characterized in actinobacterial
representatives, specifically from the genera Streptomyces [24,28] and Micromonospora [25], raising
the question of the origin of these compounds in the sea anemone extract. Thus, we cultivated the
Actinobacteria harbored by this sea anemone to determine if the anthraquinone producer was a
bacterium or the sea anemone. Isolation media and the respective obtained strains are specified in
Supplementary Table S1. Ten strains were identified through analysis of the 16S rRNA gene sequences
as members of the genera Micromonospora, Streptomyces, Verrucosispora, Dietzia, Arthrobacter, Rhodococcus,
and Cellulosimicrobium (Figure 3). Remarkably, Gyractis sesere harbors a high number of Actinobacteria
genera, in total seven; the most abundant genus being Micromonospora with three different species,
followed by Arthrobacter with two different species. Other actinobacterial genera were present with
only one species each. Outstandingly, the only isolate belonging to the Verrucosispora genus was the
most abundant single Actinobacterium in the sea anemone.
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2.3. Bacterial Growth
To evaluate the production of the anthr i s y the isolated bacteria, we sel cted the
actinobacterial representatives for gro th experi ents that were most closely related to known
producers of the genera Streptomyces, Micromonospora and Verrucosispora. In addition, we also grew the
Dietzia representative due to the lack of comprehensive information about its secondary metabolite
production. On the other hand, Rhodococcus, Arthrobacter, and Cellulosimicrobium were omitted here
because of their known poor production of secondary metabolites.
The growth yield of the selected Actinobacteria was in the range of 20 to 100 mg crude extract.
The chromatograms of HPLC analyses of the crude extracts were compared in order to facilitate the
metabolic comparison between grown bacteria, the sea anemone and the pure substances (Figure 4).
Mar. Drugs 2019, 17, 154 5 of 15
Mar. Drugs 2019, 17, x FOR PEER REVIEW 5 of 15 
 
 
Figure 4. HPLC chromatograms of the crude extracts of the sea anemone Gyractis sesere, its respective 
actinobacterial isolates, and the purified anthraquinones, Lupinacidin A (1) and Galvaquinone B (2). 
Approximate retention times of Lupinacidin A (1) and Galvaquinone B (2) are highlighted by boxes. 
By comparison of chromatograms and retention times, we observed that Lupinacidin A (1) and 
Galvaquinone B (2) were only present in the crude extract of the sea anemone Gyractis sesere and 
Verrucosispora sp. SN26_14.1, and not in the other actinobacterial representatives. Clearly, 
Verrucosispora must be the producer of the anthraquinones. Further, it is obvious that the metabolites 
of Verrucosispora sp. strain SN26_14.1 are dominant in the marine invertebrate. The chromatograms 
of Verrucosispora and sea anemone extracts are nearly identical and differ only slightly in the region 
of retention time 20–23 min. Notably the chromatogram of the sea anemone extract also does not 
show any peaks that suggest the presence of metabolites of any other of the cultivated bacteria. 
Together, this strongly suggests Verrucosispora appeared to be the most abundant microbe in the sea 
anemone biomass during the collection.  
The subtle difference in the metabolite profiles between Verrucosispora and sea anemone extract 
in the retention time region 20–23 min appears to be to metabolites produced by the sea anemone 
itself. Overall, the amount appears to be surprisingly small. This may however be caused by the 
isolation methodology (chloroform extraction), that prioritizes lipophilic substances and selects 
against the isolation of polar compounds such as peptides.   
2.4. Actinobacterial producer 
To confirm and replicate the production of these metabolites, we undertook a scale up culture 
of Verrucosispora sp. SN26_14.1. Thus, 10 L of the Actinobacterium culture were grown, and extracted 
through the use of amberlite XAD-16 resin, yielding 1 g of crude extract with a brownish coloration. 
This extract was subjected to stepwise flash chromatography using iso-octane and ethyl acetate 
gradients, which produced a total of ten fractions. The fractions were evaluated through HPLC to 
find the fractions containing Lupinacidin A (1) and Galvaquinone B (2). The chromatogram 
evaluation showed that only the orange colored fraction two, which was eluted with 90% iso-octane 
and 10% ethyl acetate, contained 78 mg of metabolites enriched with Lupinacidin A (1) and 
Galvaquinone B (2). The purification of Lupinacidin A (1) and Galvaquinone B (2) was achieved 
through HPLC using normal and reverse phase chromatography. 
Figure 4. HPLC chromatograms of t e cr e e tracts of the sea anemone Gyractis sesere, its respective
actinobacterial isolates, and the purified anthraquinones, Lupinacidin A (1) and Galvaquinone B (2).
Approximate retention times of Lupinacidin A (1) and Galvaquinone B (2) are highlighted by boxes.
By comparison of chromatogra s and retention times, we observed that Lupinacidin A (1) and
Galvaquinone B (2) were only present in the crude extract of the sea anemone Gyractis sesere and
Verrucosispora sp. SN26_14.1, and not in the other actinobacterial representatives. Clearly, Verrucosispora
must be the producer of the anthraquinones. Further, it is obvious that the metabolites of Verrucosispora
sp. strain SN26_14.1 are dominant in the marine invertebrate. The chromatograms of Verrucosispora
and sea anemone extracts are nearly identical and differ only slightly in the region of retention time
20–23 min. Notably the chromatogram of the sea anemone extract also does not show any peaks that
suggest the presence of metabolites of any other of the cultivated bacteria. Together, this strongly
suggests Verrucosispora appeared to be the most abundant microbe in the sea anemone biomass during
the collection.
The subtle difference in the metabolite profiles between Verrucosispora an sea anemone extract in
the r tention time region 20–23 min appears to be to metabolites produced by the sea anemone itself.
Overall, the amount appears to be surprisingly sm ll. This may however be caused by the isolation
methodology (chlorof rm extracti n), that prioritizes lipophilic substances and selects against the
isolation of polar compounds such as peptides.
2.4. Actinobacterial Producer
To confirm and replicate the production of these metabolites, we undertook a scale up culture of
Verrucosispora sp. SN26_14.1. Thus, 10 L of the Actinobacterium culture were grown, and extracted
through the use of amberlite XAD-16 resin, yielding 1 g of crude extract with a brownish coloration.
This extract was subjected to stepwise flash chromatography using iso-octane and ethyl acetate
gradients, which produced a total of ten fractions. The fractions were evaluated through HPLC to find
the fractions containing Lupinacidin A (1) and Galvaquinone B (2). The chromatogram evaluation
showed that only the orange colored fraction two, which was eluted with 90% iso-octane and 10%
ethyl acetate, contained 78 mg of metabolites enriched with Lupinacidin A (1) and Galvaquinone B
(2). The purification of Lupinacidin A (1) and Galvaquinone B (2) was achieved through HPLC using
normal and reverse phase chromatography.
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Lupinacidin A (1) was isolated as a yellow powder, with a yield of 11 mg from a 10 L culture,
which suggested to be an intermediate yield compared with Streptomyces and Micromonospora
producers [24,25,28]. High resolution APCI-MS gave an [M + H]+ adduct of m/z 341.1378, which
results in a molecular formula of C20H20O5. The calculation of the degree of unsaturation indicated
11 degrees. 1H NMR showed the characteristic exchangeable protons of (1) at δ at 14.18 and 12.96 ppm,
in addition to the three neighboring aromatic proton signals δ 7.26, 7.62, and 7.79 ppm that showed
the expected coupling pattern for three neighboring aromatic protons in a para-ortho, ortho-meta
relationship (two duplets, and one duplet of duplets). The 13C NMR experiment showed 20 carbons of
which two represented ketone signals (δ 190.2 and 186.9 ppm), 12 aromatic carbons, and six aliphatic
carbons (see Table 1). Two-dimensional NMR experiments, Homonuclear COrrelated SpectroscopY
(COSY), Heteronuclear Single Quantum Correlation (HSQC), and Heteronuclear Multiple Bond
Correlation (HMBC), helped to confirm the identity of the molecules. These data were in agreement
with the published information [24,25,28].
Table 1. Spectroscopic NMR data of Lupinacidin A (1) and Galvaquinone B (2).
Lupinacidin
A
Galvaquinone
B
Position δC
δH Mult
(J in Hz) HMBC COSY δC
δH Mult
(J in Hz) HMBC COSY
1 162.5 157.5
2 117.5 137.1
3 159.6 141.1
4 130.4 153.8
4a 127.9 116.2
5 190.2 190.7
5a 117.1 116.2
6 162.6 162.7
7 124.3 7.26, d(8.2) 5a, 6, 9 H-8 124.8
7.32, d
(8.5, 1.3) 5a, 6, 9 H-8
8 136 7.62, dd(8.2, 7.5) 6, 9a H-7, H-9 137.1
7.72, dd
(8.5, 7.6) 6, 9, 9a H-7, H-9
9 118.3 7.79, d(7.5) 5a, 7, 10 H-8 119.7
7.90, d
(7.6, 1.3) 5a, 7, 10, H-9
9a 133 133.4
10 186.9 186.5
10a 110.8 111.7
11 8.4 2.27, s 1, 2, 3 13.2 2.25, s 1, 2, 3
12 24.8 3.21, m(6.6)
3, 4a, 13,
14 H-13 204.9
13 37.7 1.46, m(6.6)
4a, 12, 14,
15
H-12,
H-14 42.4 2.85, m 12, 14, 15 H-14
14 28.4 1.80, m(6.6)
12, 13, 15,
16
H-13,
H-15,
H-16
31.9 1.63, m 14, 15, 16,17 H-15
15 22.5 1.04, d(6.6) 13, 14, 16 H-14 27.6 1.63, m
14, 15, 16,
17
H-13,
H-16,
H-17
16 22.5 1.04, d(6.6) 13, 14, 15 H-14 22.4
0.93, d,
(6.2) 14, 15, 17 H-15
17 22.4 0.93, d,(6.2) 14, 15, 16 H-15
1-OH 14.18 1, 2, 10a, 13.49, s 1, 2, 10a
3-OH 5.62 2, 4a, 3
4-OH 12.50, s 3, 4, 10a
6-OH 12.96 5a, 6, 7 12.14, s 5a, 6, 8
** 1H NMR (600 MHz) Solvent: CDCl3 (δ1H, mult, J in Hz), *** 13C NMR (125 MHz), Solvent: CDCl3.
Galvaquinone B (2) was isolated as a red powder, with a yield of 7 mg from a 10 L culture, which
is an intermediate yield compared with Streptomyces and Micromonospora producers [24,28]. High
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resolution APCI-MS gave an [M + H]+ adduct of m/z 369.3510 and a molecular formula of C21H20O6.
The calculation of the degree of unsaturation indicated 12 degrees. Galvaquinone B (2) showed
characteristic exchangeable proton signals at δ 13.49, 12.50, and 12.14 ppm, respectively. Aromatic
signals were similar to those found in compound (1), showing three neighboring aromatic protons
in a para-ortho, ortho-meta relationship (two duplets, and one duplet of duplets), but with a higher
frequency (see Table 1). The 13C NMR experiment showed 21 carbons of which three represented
ketone signals (δ 205, 190.2 and 186.9 ppm), 12 aromatic carbons, and six aliphatic carbons (see Table 1).
Two dimensional experiments (COSY, HSQC, HMBC) confirmed the identity of the molecules and
were in agreement with the published data [24,28].
2.5. Phylogeny of the Producer
To determine whether the present isolate was a new species and to evaluate its evolutionary
relationship, we performed a phylogenetic evaluation of the strain based of the 16S rRNA gene
sequence (Figure 5). The evaluation of the 16S gene showed a high similarity (99%) to the next related
type strain, Verrucosispora maris DSM 45365T. However, analysis of the gyrase subunit B taxonomic
marker (gyrB) showed 94.4% similarity to Verrucosispora maris DSM 45365T. The construction of
the phylogenetic tree with the closest relatives in terms of the 16S rRNA gene sequence as well as
known producers of (1) and (2) confirmed that the producer strain SN26_14.1 belongs to the genus
Verrucosispora, and that quite likely it represents a new species within the genus. This result represents
the first report of anthraquinone production for the Verrucosispora genus. Interestingly, it appears
that anthraquinones are more widespread metabolites in the Actinobacteria phylum, since compounds
(1) and (2) have now been found in three actinobacterial genera, Micromonospora, Streptomyces, and
Verrucosispora producers [24,25,28].
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2.6. Biosynthesis
Recently, the biosynthetic machinery for the production of compound (1) and (2) was described
as a type II polyketide synthase (PKS) that features a special Baeyer−Villiger type rearrangement, and
was allocated to an Rsd gene cluster in Streptomyces olivaceus SCSIO T05 [28]. The Rsd biosynthetic gene
cluster (BGC) showed great similarity to the Rsl BGC reported for the production of rishirilide A and B
in Streptomyces bottropensis (also known as Streptomyces. sp. Gç C4/4) [29]. The BGC Rsd is responsible
for the production of six molecules (rishirilide B, rishirilide C, Lupinacidin A (1), Lupinacidin D,
Galvaquinone A and Galvaquinone B (2)), and among them compound (1) and (2) [28]. This raised the
question of whether in Verrucosispora, compounds (1) and (2) follow the same biochemical assembly
line as described for Streptomyces. Thus, the genome of Verrucosispora sp. SN26_14.1 was sequenced
using Illumina MiSeq. Although the obtained short reads were not complemented with a long read
sequencing technology as PacBio, we were still able to obtain a 6.9 Mb draft genome (NCBI Bioproject
Access # PRJNA522941). This data was annotated with Prokka and analyzed with the Antismash
online platform [30] to identify the secondary metabolite biosynthesis gene clusters. As shown in
Figure 6, the draft genome of Verrucosispora sp. SN26_14.1 shared 60% of the genes of the Rsd gene
cluster, as well as to an important percentage of the genes of the Rsl BGC. The similarity of the found
genes ranged from 49% to 81%. The genetic architecture found in Vex BGC was quite similar to that of
the Rsd and Rsl BGC. Remarkably, we could not detect any cyclase/aromatase and amidohydrolase
sequences in our draft genome. Likely, this relates to the incompleteness of our sequence. Finally, it
appears reasonable that Verrucosispora sp. SN26_14.1 follows the same biosynthetic machinery for the
production of Lupinacidin A (1) and Galvaquinone B (2) as found for Streptomyces species (Figure 6).
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T05 gene cluster [28], Rsl: Streptomyces sis (Streptomyces. sp. Gc C4/4) gene cluster [29],
Vex: Ve ruco ispora sp. SN26_14.1. C1: aromatase, K1: a yl carrier protein, K2: ketosynthase (beta),
K3: t ase l a), : tr , 4: acyl-ACP synthase I, 1: BC-transporter
(substrate bindi g), T2: ABC-trans rt r ( binding), T3: ABC-transporter trans-membrane,
O1: luciferase-like onooxygenase, O2: flavin reductase, P: phosphotransferase, R1: SARP family
regulator, C2: second ring cyclase, O3: 3-oxoacyl-ACP reductase, O4: anthrone onooxygenase, O5:
NADH: flavin oxidoreductase, C3: cyclase, R2: SARP regulatory protein, R3: LAL-family regulator,
O6: luciferase-like monooxygenase, R4: MarR family transcriptional regulator, T4: drug resistance
transporter, O7: putative NADPH quinone reductase, O8: putative NADPH: quinone oxidoreductase,
O9: FAD-dependent oxidoreductase, O10: C9-keto reductase, H: amidohydrolase, -3: unknown
function, -2: major facilitator superfamily protein, -1: Transcriptional regulatory protein, 1: cupin, 2:
citrate/H+ symporter, 3: transcriptional regulator.
2.7. Antibiotic Activity Test
We performed a disc diffusion antibiotic test as a preliminary evaluation to determine if
Lupinacidin A (1) and Galvaquinone B (2) have an inhibition effect on bacteria. As a positive control,
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we used streptomycin at a concentration of 25 µg/disc. The results showed that Lupinacidin A (1)
and Galvaquinone B (2) did not produce any growth inhibition against the Gram-positive bacterium
Staphylococcus lentus DSM 20352T, and neither against the Gram-negative bacterium Escherichia coli
DSM 498T. In contrast, the positive control, streptomycin produced an inhibition halo of 22 mm for
Gram-negative and 18 mm for Gram-positive bacteria.
3. Materials and Methods
3.1. Sample Collection
The sea anemone Gyractis sesere (also known as Actiniogeton rapanuiensis) was sampled from
the coastal zone of Easter Island (27◦08′45.1”S, 109◦25′50.0”W) by the first author (Chilean citizen),
in March 2016. The sampling site was outside the Isla de Pascua national park, and the sample was
taken in agreement with regulations by the Chilean government. The sample was stored at 0 ◦C one
hour after the sampling process.
3.2. Sea Anemone Dereplication
10 g of the sea anemone Gyractis sesere (wet weight) were thawed and homogenized with a mortar
and pestle. When a creamy consistency was obtained, the tissue was transferred to a 250 mL beaker
and 50 mL of chloroform was added. This extraction procedure was repeated three times. The obtained
chloroform extract was concentrated until dryness under reduced pressure in a rotatory evaporator.
The dried extract was resuspended in 1 L deionized water and transferred to a separation funnel,
where it was partitioned with chloroform (3 × 300 mL). This process produced 8 mg of crude extract
with a brownish coloration. Part of the crude extract (0.5 mg) was resuspended in methanol (HPLC
grade) and injected in a HPLC (Merck Hitachi LaChrom Elite, Darmstadt, Germany) and in a HRLCMS
Thermo Scientific™ Q Exactive™ Hybrid-Quadrupol-Orbitrap (Bremen, Germany), positive mode,
and a 30 minute gradient of H2O and acetonitrile supplemented with 0.1% of formic acid. The gradient
developed as following: 0 min: 90% water, 10% acetonitrile, 25 min: 0% water, 100% acetonitrile,
28 min: 0% water, 100% acetonitrile, 30 min: 90% water, 10% acetonitrile. Mass spectroscopic data was
evaluated with Xcalibur® (Thermo Fisher Scientific, San Jose, CA, USA), and compared with online
databases (MarinLit, and Scifinder), and literature. The entire remaining sample was dissolved in
deuterated chloroform (Eurisotop™, Saint-Aubin, France) and analyzed by 1H NMR using a Bruker
(Rheinstetten, Germany) Avance 600 MHz NMR spectrometer.
3.3. Bacterial Isolation
Approximately 1 cm3 (2 g) of the sea anemone Gyractis sesere (wet weight) were thawed and
homogenized with a sterile mortar and pestle. Subsequently, the homogenized tissue was mixed
with 9 mL of Ringer’s buffer 14 strength [31] to produce a final solution of 1:10. This solution was
incubated at 56 ◦C for 10 min with the aim of reducing the viability of non-actinobacterial microbes.
After the incubation, 1 min of vortex was applied. The inoculation of the culture media was done by
adding 50 µL of the dilution into 15 cm diameter Petri dishes containing the media. The inoculum was
spread out on the plate with a triangular cell spreader made of glass. Finally, plates were incubated
at 25 ◦C in darkness. Darkness was chosen as a filtering factor to eliminate potential microalgae
contamination. Four different media were prepared for the isolation of Actinobacteria from the sea
anemone Gyractis sesere. Medium SIMA1 (Salinispora isolation media A1) was selected from literature
and slightly modified as follows: 2.5 g starch, 1 g yeast extract, 0.5 g peptone, 1 L deionized water, and
25 g Tropic Marin™ salt (Wartenberg, Germany), 15 g/L agar [32]. The other media (BCM, BTM, and
BSEM) were generated for this study as follows: BCM, 3 g chitin, 0.5 g N-acetyl glucosamine, 0.2 g
K2HPO4, 0.25 g KNO3, 0.25 g casein, 5 mL of mineral solution, 4 mL vitamin solution, 1 L deionized
water, 15 g/L Tropic Marin™ salt (Wartenberg, Germany), 12 g/L Gellan gum, pH = 7.35; BTM, 1 g
trehalose, 0.25 g histidine, 0,25 g proline, 0.2 g MgCl2*6H2O, 4 mL vitamin solution, 12 g/L Gellan
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gum, 1 L deionized water, 15 g Tropic Marin™ salt (Wartenberg, Germany), pH = 7.2; and BSEM,
0.1 g tyrosine, 0.1 g D-galactose, 4 mL vitamin solution, 5 mL mineral solution, 1 L Baltic Sea water,
16 g/L agar, pH = 7.4. Mineral salt solution contained 1 L distillated water, 50 mg FeSO4*7H2O, 50 mg
ZnCl2, and 50 mg CuSO4. Vitamin solution contained 1 L distillated water, 5 mg thiamine*HCl, 5 mg
riboflavin, 5 mg niacin, 5 mg pyrodoxine HCl, 5 mg inositol, 5 mg Ca-pantothenate, 5 mg p-amino
benzoic acid, and 2.5 mg biotin.
The media were autoclaved for 35 min at 121 ◦C. Subsequently, the culture media were
supplemented with 50 mg/L of nalidixic acid (Sigma-Aldrich, St. Louis, MO, USA) and 100 mg/L of
cycloheximide (Carl Roth GmbH, Karlsruhe, Germany) [33], and poured into petri dishes. Once the
sample was inoculated onto the petri dish, they were incubated for six weeks. When bacterial colonies
were visually evident, we proceeded with the purification of the bacteria until obtaining an axenic
culture. The isolated bacteria were conserved using Cryobank™ (Mast Diagnostica GmbH, Reinfeld,
Germany) bacterial storage system.
3.4. Molecular Characterization and Phylogenetic Analysis
DNA was extracted from bacterial cells by use of a DNA isolation kit, DNeasy™ (Qiagen, Hilden,
Germany), following the manufacturer instructions. Subsequently, the 16S rRNA gene sequence was
amplified with PCR and the use of general bacterial primers in a concentration of 10 pmol/µL, i.e., 27f
and 1492r [34], 342f and 534r [35], 1387r [36] as well as 1525r [37]. PCR reagents were obtained from GE
Healthcare Illustra™ PuReTaq Ready-To-Go™ PCR Beads (GE Healthcare, Glattbrugg, Switzerland)
containing DNA polymerase, MgCl2, and dNTPs. The PCR conditions were the same as reported by
Staufenberger et al. [35]. Once the PCR amplification process was terminated, a quality check of the
PCR products was performed by gel electrophoresis. The sequencing process was run at the Centre for
Molecular Biology at Kiel University (IKMB). The 16S rRNA gene sequences were manually curated
using Chromas pro software, version 1.7.6 (Technelysium Pty Ltd., Tewantin QLD, Australia), and
saved in FASTA format. Sequences were aligned with nucleotide BLAST [38] and EZbiocloud [39].
Phylogenetic analysis involved the alignment of the sequences with related reference strains in the web
platform SILVA-SINA [40]. MEGA was used to delete gap sites and to run bootstrapped phylogenetic
trees using a neighbor-joining model [41].
3.5. Bacterial Growth for Secondary Metabolites Production
For the evaluation of the secondary metabolites production, we grew the Easter Island isolated
strain Verrucosispora sp. SN26_14.1 in 10 × 2.5 L Thomson Ultra Yield® flasks (Thomson Instrument,
Oceanside, CA, USA), which contained 1 L each of a modified starch-glucose-glycerol (SGG) liquid
medium [31]. The composition of the production medium was: 5 g glucose, 5 g soluble starch, 5 g
glycerol, 1.25 g cornsteep powder, 2.5 g peptone, 1 g yeast extract, 1.5 CaCO3, and 1 L deionized water.
The medium was also supplemented with 15 g/L Tropic Marin™ salt (Wartenberg, Germany). The pH
was adjusted to 7.7 using 1 M HCl and NaOH. The culture was kept in orbital agitation at 240 RPM,
28 ◦C, for 14 days in darkness.
3.6. Chemical Extraction, Purification and Structure Elucidation
After the growth period, 20 g/L amberlite XAD-16 (Sigma-Aldrich, St. Louis, MO, USA) was
added to each culture medium flask and mixed for one hour using orbital agitation with 120 rpm.
Subsequently, the resin was separated through cheesecloth filtration [42], and the liquid was discarded.
Afterwards, amberlite plus cheesecloth was mounted on a glass funnel, washed with 3 L of deionized
water, and eluted with 1 L of acetone [42]. Acetone was then concentrated under reduced pressure
until an aqueous residue was obtained. One liter of deionized water was added to the acetone residue,
and it was brought to a separation funnel. The organic molecules were extracted using 3 × 1 L of ethyl
acetate. The organic phase was concentrated under reduced pressure until dryness.
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For the evaluation of the produced metabolites, we used HPLC-DAD (Merck Hitachi LaChrom
Elite, Darmstadt, Germany) and a 30 min gradient of H2O-acetonitrile supplemented with 0.1% of
formic acid. The gradient was developed as following: 0 min: 90% water, 10% acetonitrile, 25 min:
0% water, 100% acetonitrile, 28 min: 0% water, 100% acetonitrile, 30 min: 90% water, 10% acetonitrile.
The gravity SB™ C-18 column was obtained from Macherey-Nagel (Düren, Germany).
The purification of chemicals involved three different steps: 1) Flash chromatography using
standard silica gel 60, pore size ~ 60 Å (Macherey-Nagel, Düren, Germany) as a stationary phase,
mounted in a glass Buchner funnel (D = 70 mm, H = 180 mm). The mobile phase solvents were
iso-octane and ethyl acetate. The chromatographic process was developed in a stepwise increase of
polarity (10% each), starting with 100% iso-octane, and 0% of ethyl acetate, and ending in 0% iso-octane
and 100% ethyl acetate, resulting in 10 different fractions. 2) The fraction that contained compound (1)
and (2) was selected and worked in HPLC (Merck Hitachi LaChrom Elite, Darmstadt, Germany) using a
normal phase NUCLEODUR® 100-5 column (4.6 × 250 mm) from Macherey-Nagel (Düren, Germany).
The method used for the purification was a combination of isocratic and gradient solvent mix, with a
flow rate of 1 mL/min, where A: iso-octane, B: ethyl acetate, and C: dichloromethane/methanol (50:50).
The method was developed as following: 0 min: 100% A and 0% B, 3 min: 100% A and 0% B, 5 min:
95% A and 5% B, 9 min: 95% A and 5% B, 11 min: 0% A and 100% B, 13 min: 0% A and 100% B, 14 min:
10% A, 50% B, and 40% C, 16 min: 10% A, 50% B, and 40% C, 18 min: 50% A and 50% B, 19 min: 100%
A and 0% B, 21 min: 100% A and 0% B. 3) The semi-purified compounds were purified through HPLC
(Merck Hitachi LaChrom Elite, Darmstadt, Germany using a reverse phase C-18 column, 10 × 250 mm
(YMC, Kyoto, Japan). The method used for the purification was a combination of isocratic and gradient
solvent mix, with a flow rate of 2.5 mL/min. The method was developed as following: 0 min: 90% A
and 10% B, 5 min: 20% A and 80% B, 9 min: 20% A and 80% B, 13 min: 0% A and 100% B, 19 min: 0%
A and 100% B, 23 min: 90% A and 10% B, 25 min: 90% A, 10% B (A. water, B: acetonitrile).
After these purification steps, Lupinacidin A (1) and Galvaquinone B (2) were obtained with
high purity to perform structural elucidation experiments. HRLCMS was performed with a Thermo
Scientific™ Q Exactive™ Hybrid-Quadrupol-Orbitrap (Thermo Scientific, Bremen, Germany), positive
mode, and a 30 min gradient of H2O and acetonitrile supplemented with 0.1% of formic acid.
The gradient was developed as follows: 0 min: 90% water, 10% acetonitrile, 25 min: 0% water,
100% acetonitrile, 28 min: 0% water, 100% acetonitrile, 30 min: 90% water, 10% acetonitrile. Mass
spectroscopic data was evaluated with Xcalibur® (Thermo Fisher Scientific, San Jose, CA, USA), and
the compared with online databases (MarinLit, and Scifinder), and literature.
Additionally, 1H and 13C NMR and two-dimensional NMR experiments (HMBC, HSQC, COSY)
were acquired to characterize the main components of crude extract, and their chemical functionality.
For this, compound (1) and (2) were redissolved in CDCl3 (Eurisotop™, Saint-Aubin, France), and
transferred to NMR tubes (178 × 5.0 mm). Experiments were acquired on a Bruker (Rheinstetten,
Germany) Avance spectrometer operating at 600 MHz proton frequency equipped with a cryogenically
cooled triple resonance z-gradient probe head using stand pulse sequences from the Bruker experiment
library. Spectra were referenced against tetramethylsilane (Sigma-Aldrich, St. Louis, MO, USA) as
internal standard.
3.7. Genome Sequencing
The samples were prepared with the Nextera® XT DNA sample preparation kit from Illumina
(Illumina, San Diego, CA, USA) following the manufacturer’s protocol. Afterwards the samples
were pooled and sequenced on the Illumina MiSeq using the MiSeq® (Illumina, San Diego, CA, USA)
Reagent Kit v3 600 cycles sequencing chemistry. The library was clustered to a density of approximately
1200 K/mm2.
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3.8. Genome Assembly
The quality control of reads was checked with FASTQC software [43] to evaluate the GC%,
number of k-mers, sequence length, and total reads. Trimmomatic v0.36 [44] was used to filter low
quality sequences and adapters. Filtered reads were assembled with SPAdes v3.11.0 [45] using default
k-mer lengths. The obtained contigs were evaluated with QUAST tool [46] to select the best quality
contig. Finally, Prokka [47] was used to annotate the draft genome.
3.9. Secondary Metabolites Gene Clusters Search
The online platform of Antismash [30] was used to detect the secondary metabolites gene clusters
present in the draft genome.
3.10. Antibiotic Activity Test
To test the antibiotic activity, we used the disc diffusion method [48] as a primary indicator. Thus,
compound (1) and (2) were tested to determine their activity on Staphylococcus lentus DSM 20352T,
and Escherichia coli DSM 498T. These bacteria were cultured in GYM medium (4 g glucose, 4 g yeast
extract, 10 g malt extract, 2 g CaCO3, 1 L deionized water, pH = 7.2, and 12 g agar). Lupinacidin A
(1), and Galvaquinone B (2) were transferred to a paper disc to reach a final concentration of 25 µg
and 50 µg each in triplicate. Additionally, we used an antibiotic susceptibility disc of streptomycin
(Oxoid®, Columbia, MD, USA) as a positive indicator of antibiotic activity. The plates were inoculated
with fresh culture of Staphylococcus lentus DSM 20352T, and Escherichia coli DSM 498T, and incubated at
37 ◦C for 24 h. After the incubation period, the inhibition zone was measured and registered.
4. Conclusions
We established that the Easter Island sea anemone Gyractis sesere contained two anthraquinones,
Lupinacidin A (1) and Galvaquinone B (2), which were ultimately found to be produced by one of the
Actinobacteria associated with this marine invertebrate, Verrucosispora sp. SN26_14.1. The production
of the identified metabolites by the bacterial isolate apparently follows a recently characterized PKS
type II pathway with a Baeyer−Villiger type rearrangement assembly line. Our finding adds a new
actinobacterial genus to the producers of these anthraquinones, implying that these metabolites are
not exclusive to the genera Streptomyces and Micromonospora. It was demonstrated, that culture-based
approaches remain as effective tools for the isolation of polyketide producing Actinobacteria as sources
for secondary metabolites of potential use in drug discovery. Our study confirms that cnidarians, and
in specific sea anemones, can be a source of such pharmacologically relevant microorganisms. Finally,
these findings re-open the debate about the real producers of secondary metabolites in sea animals
and add another example of associated bacteria as producers of substances present in sea animals. In
addition, the study provides information on the chemistry harbored in biota of the geographically
isolated and almost unstudied, Easter Island.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/17/3/154/s1.
Information on NMR spectra, HRLCMS data, and secondary metabolite gene cluster.
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